Efficacy of intravenous magnesium in neuropathic pain

British Journal of Anaesthesia

Volumn 89, Issue 5, 2002, Pages 711-714

  Brill, S ^a   Sedgwick, P M ^b   Hamann, W ^a,c   Di Vadi, P P ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Pain, neuropathic; Pain, postherpetic neuralgia

Indexed keywords

ANTICONVULSIVE AGENT; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; SODIUM CHLORIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INJECTION SITE; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSORY SYSTEM; SIDE EFFECT;

EID: 0036839978     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/89.5.711     Document Type: Article

References (25)

1. Rowbotham MC, Petersen KL. Zoster-associated pain and neural dysfunction. Pain 2001; 93: 1-5
2. Kost RG, Strauss SE. Postherpetic neuralgia-pathogenesis, treatment, and prevention. New Engl J Med 1996; 335: 32-42
3. Mahalingam R, Wellish M, Wolf W, et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. New Engl J Med 1990; 323: 627-31
4. Nurmikko T. Pathophysiology of acute herpes zoster and postherpetic neuralgia. Pain Forum 1998; 4: 238-40
5. Woolf CJ, Thompson WN. The induction and maintenance of central sensitisation is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 298-9
6. Dickenson AH. NMDA receptor antagonists as analgesics. In: Fields HL, Liebeskind JC. Progress in Pain Research and Management, Volume I. Seattle; IASP Press, 1994; 173-87
7. Hoffmann V, Coppejans H, Vercauteren M, Adriaensen H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994; 10: 240-2
8. Byas-Smith MG, Max MB, Gracely RH, Bennett GJ. Intravenous ketamine and alfentanil in patients with chronic causalgic pain and allodynia [abstract]. 7th World Congress on Pain 1993; 454-5
9. Fawcet WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999; 83: 302-20
10. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997; 73: 123-39
11. Rowbotham MC, Petersen KL, Fields HL. Is postherpetic neuralgia more than one disorder? Pain Forum 1998; 7: 231-7
12. Eclampsia Trial Collaborative Group. Which anticonvulsant for women with preeclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63
13. Ginder S, Oatman B, Pollack M. A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med 2000; 18: 311-5
14. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate alleviates headaches of various types. Headache 1996; 36: 154-60
15. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulphate in the treatment of acute migraine attacks. Headache 2001; 41: 171-7
16. Begon S, Pickering G, Eschalier A, Dubray C. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res 2000; 887: 436-9
17. Feria M, Abad F, Sanchez A, Abreu P. Magnesium sulphate injected subcutaneously suppresses autonomy in peripherally deafferented rats. Pain 1993; 53: 287-93
18. Karesawa S, Ishizaki K, Goto F. The effect of intrathecal administration of magnesium sulphate in rats. Anaesthesia 1998; 53: 879-86
19. Takano Y, Sato E, Kaneko T, Sato I. Antihyperalgesic effects of intrathecally administered magnesium sulfate in rats Pain 2000; 84: 175-9
20. Tsai P, Cheng J, Marsala M, Lin C, Wen G, Yang LC. Intrathecal magnesium sulphate attenuates algogenic behavior and spinal amino acids release after kainic acid receptor activation in rats. Neuroscience Lett 2001; 301: 115-8
21. Xiao WH, Bennett GJ. Magnesium suppresses neuropathic pain responses in rats via a spinal site of action. Brain Res 1994; 666: 168-172
22. Koinig H, Wallner T, Marhofer P, Andel H, Horauf K, Mayer N. Magnesium sulphate reduces intra-and postoperative analgesic requirements. Anesth Analg 1998; 87: 206-10
23. Schultz-Stubner S, Wettmann G, Reyle-Hahn SM, Rossaint R. Magnesium as part of balanced general anaesthesia with propofol, remifentanil and mivacurium: a double-blind, randomised prospective study in 50 patients. Eur J Anaesthesiol 1991; 18: 723-9
24. Tramer MR, Schneider J, Marti RA, Rifat K. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996; 84: 340-7
25. Crosby V, Wilcock A, Corcoran R. The safety and efficacy of a single dose (500 mg or I g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage 2000; 19: 35-9